Surgery for borderline tumor of the ovar
β
Claes G. TropΓ©; Gunnar Kristensen; Amin Makar
π
Article
π
2000
π
John Wiley and Sons
π
English
β 49 KB
π 2 views
The five-year survival for women with Stage I borderline tumors is about 95% to 97%, but because of late recurrence the 10-year survival is only 70% to 95%. The five-year survival for Stage II-III patients is 65% to 87%. A more correct staging procedure, classification of true serous implants, and a